Print this page

Observations placeholder

Zytiga

Identifier

020478

Type of spiritual experience

Hallucination (11)

A description of the experience

Abiraterone acetate (INN, USAN, BAN, JAN) (brand names Zytiga, Abiratas, Abretone, Abirapro) is a steroidal antiandrogen, specifically an androgen synthesis inhibitor, used in combination with prednisone in metastatic castration-resistant prostate cancer (formerly hormone-resistant or hormone-refractory prostate cancer) – i.e., prostate cancer not responding to androgen deprivation or treatment with androgen receptor antagonists. It is a prodrug to the active agent abiraterone, and is marketed under the trade name Zytiga.

Adverse effects

Adverse effects by frequency:very common (>10% frequency):

  • Urinary tract infection
  • Hypokalemia
  • Hypertension
  • Diarrhoea
  • Peripheral edema

Common (1-10% frequency):

  • Hypertriglyceridaemia
  • Sepsis
  • Cardiac failure
  • Angina pectoris
  • Arrhythmia
  • Atrial fibrillation
  • Tachycardia
  • Dyspepsia (indigestion)
  • Rash
  • Alanine aminotransferase increased
  • Aspartate aminotransferase increased
  • Fractures
  • Hematuria

Uncommon (0.1-1% frequency):

  • Adrenal insufficiency
  • Myopathy
  • Rhabdomyolysis

Rare (<0.1% frequency):

  • Allergic alveolitis

On Dec, 25, 2016   6,388 people reported to have side effects when taking Zytiga.
Among them, 11 people (0.17%) have Hallucination

 

On Feb, 6, 2016: 781 people reported to have side effects when taking Zytiga. Among them, 53 people (6.79%) have Death.

Time on Zytiga when people have Death  :

  < 1 month 1 - 6 months 6 - 12 months 1 - 2 years 2 - 5 years 5 - 10 years 10+ years
Death 43.75% 37.50% 18.75% 0.00% 0.00% 0.00% 0.00%

 

 

The source of the experience

eHealthme

Activities

Observation contributed by: Julie Usher